Loading

AARD — Aardvark Therapeutics, Inc. · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

AARD

Aardvark Therapeutics, Inc.—15-min delayed · EOD close

4.92▼ −7.69% downas of 2026-09-09mkt cap $108M

Pharmaceutical Preparations · SIC 2834 · CIK 0001774857

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Market cap

$108M

P/E

—

Net margin

—

ROE

-93.4%

Revenue

—

latest annual

Net income

−$69.9M

latest annual

Shares out

21.9M

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

Free cash flow

−$69.4M

52-week range

Current: 4.92

▲

Low

4.92

High

7.90

Quality score

—/100

Growth0

missing: revenueGrowth

Business qualityno data

missing: grossMargin, operatingMargin, netMargin

Financial health100

Valuationno data

missing: peRatio, psRatio

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.